We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$48B
AUM Growth
-$1.59B
Cap. Flow
-$1.46B
Cap. Flow %
-3.05%
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$60.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.8M
3
MA icon
Mastercard
MA
+$43.1M
4
ADI icon
Analog Devices
ADI
+$40.3M
5
AVGO icon
Broadcom
AVGO
+$40.1M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$92.3M
2
NVDA icon
NVIDIA
NVDA
+$92.1M
3
LLY icon
Eli Lilly
LLY
+$80.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$74.2M
5
MSFT icon
Microsoft
MSFT
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Financials 15.08%
3 Healthcare 14.69%
4 Consumer Discretionary 11.11%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIC icon
1851
American Coastal Insurance
ACIC
$505M
-25,215
Closed -$144K
AXSM icon
1852
Axsome Therapeutics
AXSM
$12.3B
-11,597
Closed -$782K
BABA icon
1853
Alibaba
BABA
$276B
-25,000
Closed -$5.67M
BAH icon
1854
Booz Allen Hamilton
BAH
$8.59B
-41,785
Closed -$3.56M
CG icon
1855
Carlyle Group
CG
$16.7B
-2,345
Closed -$109K
DOYU
1856
DouYu International Holdings
DOYU
$135M
-815
Closed -$56K
ERIE icon
1857
Erie Indemnity
ERIE
$11.9B
-290
Closed -$56K
FATE icon
1858
Fate Therapeutics
FATE
$283M
-7,039
Closed -$611K
FIVN icon
1859
FIVE9
FIVN
$1.96B
-12,287
Closed -$2.25M
HLF icon
1860
Herbalife
HLF
$1.26B
-7,465
Closed -$394K
HLX icon
1861
Helix Energy Solutions
HLX
$1.42B
-57,100
Closed -$326K
PPLI
1862
People Inc
PPLI
$3.15B
-2,822
Closed -$357K
KALA icon
1863
KALA BIO
KALA
$12.5M
-18
Closed -$244K
KALV
1864
DELISTED
KalVista Pharmaceuticals
KALV
-47,116
Closed -$1.13M
KOD icon
1865
Kodiak Sciences
KOD
$2.62B
-1,000
Closed -$93K
LAZ icon
1866
Lazard
LAZ
$4.23B
-5,785
Closed -$262K
LPLA icon
1867
LPL Financial
LPLA
$26.5B
-1,695
Closed -$229K
NXST icon
1868
Nexstar Media Group
NXST
$5.67B
-1,590
Closed -$235K
OLMA icon
1869
Olema Pharmaceuticals
OLMA
$1.05B
-9,800
Closed -$275K
PAG icon
1870
Penske Automotive Group
PAG
$14.2B
-4,024
Closed -$304K
PASG icon
1871
Passage Bio
PASG
$14.8M
-1,283
Closed -$340K
PTGX icon
1872
Protagonist Therapeutics
PTGX
$8.72B
-33,230
Closed -$1.49M
ROOT icon
1873
Root
ROOT
$944M
-151,917
Closed -$29.6M
RPRX icon
1874
Royalty Pharma
RPRX
$26B
-2,530
Closed -$104K
RYTM icon
1875
Rhythm Pharmaceuticals
RYTM
$7.28B
-40,891
Closed -$801K

Similar funds

Ensign Peak Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.

  • Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
  • Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
  • Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
  • Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
  • Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
  • Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
  • Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.

Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.